A detailed history of Cowen Prime Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 62,960 shares of PFE stock, worth $1.68 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
62,960
Previous 65,860 4.4%
Holding current value
$1.68 Million
Previous $2.56 Million 9.84%
% of portfolio
0.8%
Previous 1.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $104,747 - $121,191
-2,900 Reduced 4.4%
62,960 $2.31 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $82,125 - $97,375
-1,765 Reduced 2.61%
65,860 $3.45 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $190,072 - $281,750
-4,600 Reduced 6.37%
67,625 $3.99 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $228,567 - $258,928
6,365 Added 9.66%
72,225 $2.83 Million
Q2 2020

Aug 01, 2022

BUY
$30.12 - $36.54 $1.98 Million - $2.41 Million
65,860 New
65,860 $3.45 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cowen Prime Advisors LLC Portfolio

Follow Cowen Prime Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen Prime Advisors LLC with notifications on news.